The potential of B7-H6 as a therapeutic target in cancer immunotherapy.

Mohammadi, Alaleh; Najafi, Souzan; Amini, Mohammad; Mansoori, Behzad; Baghbanzadeh, Amir; Hoheisel, Jörg D; Baradaran, Behzad

Mohammadi, Alaleh; Najafi, Souzan; Amini, Mohammad; Mansoori, Behzad; Baghbanzadeh, Amir; Hoheisel, Jörg D; Baradaran, Behzad.

Affiliation

Mohammadi A; Department of Pathobiology, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Najafi S; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Amini M; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Mansoori B; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Baghbanzadeh A; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Hoheisel JD; Division of Functional Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Baradaran B; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: baradaranb@tbzmed.ac.ir.

Life Sci ; 304: 120709, 2022 Sep 01.

Article de En | MEDLINE | ID: mdl-35697295

Sujet(s)
Mots clés

B7-H6; Immune checkpoint; STAT3 pathway; Tumorigenesis; cancer

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Récepteur-3 de déclenchement de cytotoxicité naturelle / Tumeurs Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Life Sci Année: 2022 Type de document: Article Pays d'affiliation: Iran Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google